Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

Trichlormethiazide - Generic Drug Details

« Back to Dashboard

What are the generic sources for trichlormethiazide and what is the scope of patent protection?

Trichlormethiazide
is the generic ingredient in five branded drugs marketed by Par Pharm, Lannett, Watson Labs, Mast Mm, Schering, Impax Labs, Tg United Labs, Sandoz, and Sanofi Aventis Us, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for trichlormethiazide.

Summary for Generic Name: trichlormethiazide

Tradenames:5
Patents:1
Applicants:9
NDAs:15
Drug Master File Entries: see list1
Bulk Api Vendors: see list38
Patent Applications: see list3,664
Therapeutic Class:Cardiovascular Agents
Drug Prices:see low prices
DailyMed Link:trichlormethiazide at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering
NAQUA
trichlormethiazide
TABLET;ORAL012265-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL086458-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL083462-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
METAHYDRIN
trichlormethiazide
TABLET;ORAL012594-002Jun 16, 1988DISCNNoNo► Subscribe► Subscribe
Watson Labs
TRICHLORMETHIAZIDE
trichlormethiazide
TABLET;ORAL085962-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot